New rules needed to weed out Big Pharma's unethical 'seeding studies,'

[Anonymous]

http://www.minnpost.com/healthblog/...udies_says_u_bioethicist#.TjnWvIoCSRI.twitter

 

[Anonymous]

http://www.minnpost.com/healthblog/...udies_says_u_bioethicist#.TjnWvIoCSRI.twitter

Not well written or researched. Seems author had axe to grind with pharma

 

[Anonymous]

Eliminate all SD's.

The SD Assistants and OP's personnel can be retained to shuffle reports and paperwork to one of 4 area directors.

Retain 3 DBM's per state; A side; B side; 1 for Specialty/Institutional.

Then start swinging the axe at the bloated underbelly of sales training, marketing, legal & myriad of loiterers and others performing zero revenue generating tasks and support at corporate.

Retain non-core businesses showing any positive growth.

Expand the generic business worldwide.

Be wary of emerging markets that will implement nationalized healthcare cost controls...the ROI may never come to fruition.

Diversify into devices and other medical arenas where generic incursion is not always nipping at your heels.

Re-think the massive cuts to R&D and focus on innovation, making existing portfolio better (better formulations and slow release coatings), more indications for existing portfolio while eyeing the landscape for strategic co-promotions and niche acquisitions.

Implement corporate-wide wage freezes and where appropriate... wage and bonus reductions (middle and upper managment/corporate hangers-on).

Better to be employed with livable wages and health benefits than to be on the outside looking in. Desperate times call for dramatic actions. The ship is sinking and there are not enough life boats to meet the needs of everyone on board.

Move the HQ's to NJ for the tax benefits and get the hell out of tax sucking NY!

The BOD's could also use a makeover.

Purge the military and Mormon blind sheep mindset and attract/retain/promote those with entreprenurial sales skills. Enough of the Pfizer cult of nepotism that rewards those that simply check the box with "activities" vs growing sales. A top to bottom corporate makeover is long overdue in order to reverse the declines of this once proud and formerly respected organization.